BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee CH, Ali RH, Rouzbahman M, Marino-Enriquez A, Zhu M, Guo X, Brunner AL, Chiang S, Leung S, Nelnyk N, Huntsman DG, Blake Gilks C, Nielsen TO, Dal Cin P, van de Rijn M, Oliva E, Fletcher JA, Nucci MR. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement. Am J Surg Pathol 2012;36:1562-70. [PMID: 22982899 DOI: 10.1097/PAS.0b013e31825fa931] [Cited by in Crossref: 148] [Cited by in F6Publishing: 153] [Article Influence: 14.8] [Reference Citation Analysis]
Number Citing Articles
1 Hussaini HM, Seo B, Rich AM. Immunohistochemistry and Immunofluorescence. Methods in Molecular Biology 2023. [DOI: 10.1007/978-1-0716-2780-8_26] [Reference Citation Analysis]
2 Rahaman J, Cohen CJ. Gynecologic Sarcomas. Holland‐Frei Cancer Medicine 2022. [DOI: 10.1002/9781119000822.hfcm108.pub2] [Reference Citation Analysis]
3 Croce S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, Treilleux I, Neuville A, Arnould L, Just PA, Belda MALF, Averous G, Leroux A, Mery E, Loussouarn D, Weinbreck N, Le Guellec S, Mishellany F, Morice P, Guyon F, Genestie C. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group. Gynecol Oncol 2022:S0090-8258(22)00515-7. [PMID: 36114030 DOI: 10.1016/j.ygyno.2022.07.031] [Reference Citation Analysis]
4 Lee Y, Lee C. Undifferentiated Endometrial Carcinoma—Diagnostic and Therapeutic Challenges. AJSP: Reviews and Reports 2022;27:208-211. [DOI: 10.1097/pcr.0000000000000525] [Reference Citation Analysis]
5 Bhatt A, Mishra S, Glehen O. Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site—a Review. Indian J Surg Oncol 2022. [DOI: 10.1007/s13193-022-01612-9] [Reference Citation Analysis]
6 Agaimy A, Clarke BA, Kolin DL, Lee CH, Lee JC, McCluggage WG, Pöschke P, Stoehr R, Swanson D, Turashvili G, Beckmann MW, Hartmann A, Antonescu CR, Dickson BC. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma. Am J Surg Pathol 2022. [PMID: 35575789 DOI: 10.1097/PAS.0000000000001915] [Reference Citation Analysis]
7 Alkanat NE, Uner A, Usubutun A. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis. Int J Surg Pathol 2022;:10668969221098087. [PMID: 35506912 DOI: 10.1177/10668969221098087] [Reference Citation Analysis]
8 Kommoss FKF, Chiang S, Köbel M, Koelsche C, Chang KT, Irving JA, Dickson B, Thiryayi S, Rouzbahman M, Rasty G, von Deimling A, Lee CH, Turashvili G. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications. Am J Surg Pathol 2022. [PMID: 35499168 DOI: 10.1097/PAS.0000000000001909] [Reference Citation Analysis]
9 Mirkovic J. Uncommon and Difficult High-Grade Endometrial Carcinomas. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.02.007] [Reference Citation Analysis]
10 Yamaguchi K. Personalized Treatment in Uterine Sarcoma. Personalization in Gynecologic Oncology 2022. [DOI: 10.1007/978-981-19-4711-7_4] [Reference Citation Analysis]
11 Grifone TJ, Crum CP. Uterus. Handbook of Practical Immunohistochemistry 2022. [DOI: 10.1007/978-3-030-83328-2_20] [Reference Citation Analysis]
12 Kilgore J, Bowers R, Denning K, Bou Zgheib N. Positive BCOR ITD high grade endometrial stromal sarcoma discovered after miscarriage. Human Pathology: Case Reports 2021;25:200525. [DOI: 10.1016/j.ehpc.2021.200525] [Reference Citation Analysis]
13 Ou WB, Lundberg MZ, Zhu S, Bahri N, Kyriazoglou A, Xu L, Chen T, Mariño-Enriquez A, Fletcher JA. YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways. Oncogenesis 2021;10:37. [PMID: 33947829 DOI: 10.1038/s41389-021-00327-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sharma J, Anupma A, Mazumdar B, Banik D, Sarkar A. UNDIFFERENTIATED ENDOMETRIAL SARCOMA: THERAPEUTIC CHALLENGES DESPITE GOOD SURGICAL RESECTION. IJAR 2021. [DOI: 10.36106/ijar/4011734] [Reference Citation Analysis]
15 Erşan Erdem B, Erdem H. Uterine Perivascular Epithelioid Cell Tumor Diagnostic Differences Between Endometrial Curettage Material and Resection Material and Histopathological and Immunohistochemical Approach to the Difficulties in Differential Diagnosis. Black Sea Journal of Health Science 2021. [DOI: 10.19127/bshealthscience.922813] [Reference Citation Analysis]
16 Euscher ED, Buza N, Hui P. Immunohistochemistry. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_15] [Reference Citation Analysis]
17 Akiyama M, Oonishi K, Aoki K, Koshiba H. A case of low-grade endometrial stromal sarcoma diagnosed after total laparoscopic hysterectomy: A case report. JAPANESE JOURNAL OF JSGOE 2021;37:135-140. [DOI: 10.5180/jsgoe.37.1_135] [Reference Citation Analysis]
18 Zhang H, Hicks DG. Breast and Gynecologic Tumors. Practical Oncologic Molecular Pathology 2021. [DOI: 10.1007/978-3-030-73227-1_5] [Reference Citation Analysis]
19 Momeni-Boroujeni A, Mohammad N, Wolber R, Yip S, Köbel M, Dickson BC, Hensley ML, Leitao MM Jr, Antonescu CR, Benayed R, Ladanyi M, Lee CH, Chiang S. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma. Mod Pathol 2021;34:1008-16. [PMID: 33077922 DOI: 10.1038/s41379-020-00705-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
20 Utpatel K, Calvisi DF, Köhler G, Kühnel T, Niesel A, Verloh N, Vogelhuber M, Neu R, Hosten N, Schildhaus HU, Dietmaier W, Evert M. Complexity of PEComas : Diagnostic approach, molecular background, clinical management. Pathologe 2020;41:9-19. [PMID: 31309284 DOI: 10.1007/s00292-019-0612-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
21 Alabiad MA, Harb OA, Abdelfattah MT, El-shafaay BS, El-taher AK, El-hendawy EI. The values of Transgelin, Stathmin, BCOR and Cyclin-D1 expression in differentiation between Uterine Leiomyosarcoma (ULMS) and Endometrial Stromal Sarcoma (ESS); diagnostic and prognostic implications. Surg Exp Pathol 2020;3. [DOI: 10.1186/s42047-020-00065-0] [Reference Citation Analysis]
22 Subbaraya S, Murthy SS, Devi G S. Immunohistochemical and Molecular Characterization of Endometrial Stromal Sarcomas. Clin Pathol 2020;13:2632010X20916736. [PMID: 32524088 DOI: 10.1177/2632010X20916736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Hirsch MS, Watkins J. A Comprehensive Review of Biomarker Use in the Gynecologic Tract Including Differential Diagnoses and Diagnostic Pitfalls. Adv Anat Pathol 2020;27:164-92. [PMID: 31149908 DOI: 10.1097/PAP.0000000000000238] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
24 Bhatt A, Parikh L, Mishra S, Glehen O. Approach to a Patient with Peritoneal Metastases with Unknown Primary Site: Focus on Histopathological Evaluation. Pathology of Peritoneal Metastases 2020. [DOI: 10.1007/978-981-15-3773-8_11] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Malpica A, Euscher ED, Ramalingam P, Aguilera-barrantes I, Alvarado-cabrero I. Gynecological Pathology. Oncological Surgical Pathology 2020. [DOI: 10.1007/978-3-319-96681-6_15] [Reference Citation Analysis]
26 Mccluggage WG. Immunohistochemistry and Molecular Diagnostics in the Differential Diagnosis of Female Genital Tract Pathology. Gynecologic Pathology 2020. [DOI: 10.1016/b978-0-323-35909-2.00020-5] [Reference Citation Analysis]
27 Mishra S, Sinukumar S, Jumale N, Parikh L, Bhatt A, Glehen O. Rare Peritoneal Tumours: Histopathological Diagnosis and Patterns of Peritoneal Dissemination. Pathology of Peritoneal Metastases 2020. [DOI: 10.1007/978-981-15-3773-8_10] [Reference Citation Analysis]
28 Parra-herran C. Mesenchymal and Miscellaneous Lesions of the Uterus. Gynecologic Pathology 2020. [DOI: 10.1016/b978-0-323-35909-2.00011-4] [Reference Citation Analysis]
29 Fujiishi K, Nagata S, Kano R, Kubo C, Shirayanagi M, Ozaki M, Yamamoto T, Nakanishi K, Kamiura S, Nakatsuka SI. JAZF1-SUZ12 endometrial stromal sarcoma forming subserosal masses with extraordinary uptake of fluorodeoxyglucose on positron emission tomography: a case report. Diagn Pathol 2019;14:110. [PMID: 31615558 DOI: 10.1186/s13000-019-0897-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lax SF. [Mesenchymal and mixed uterine tumors : Current overview and practical aspects]. Pathologe 2019;40:36-45. [PMID: 30694356 DOI: 10.1007/s00292-019-0567-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
31 Utpatel K, Calvisi DF, Köhler G, Kühnel T, Niesel A, Verloh N, Vogelhuber M, Neu R, Hosten N, Schildhaus HU, Dietmaier W, Evert M. [Complexity of PEComas : Diagnostic approach, molecular background, clinical management (German version)]. Pathologe 2019;40:443-53. [PMID: 31165234 DOI: 10.1007/s00292-019-0614-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Rubisz P, Ciebiera M, Hirnle L, Zgliczyńska M, Łoziński T, Dzięgiel P, Kobierzycki C. The Usefulness of Immunohistochemistry in the Differential Diagnosis of Lesions Originating from the Myometrium. Int J Mol Sci 2019;20:E1136. [PMID: 30845657 DOI: 10.3390/ijms20051136] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
33 Lax SF. ♀ Mesenchymal Tumors of the Female Genital Tract. Gynecologic and Urologic Pathology 2019. [DOI: 10.1017/9781316756423.021] [Reference Citation Analysis]
34 Eamudomkarn N, Itarat Y, Kleebkaow P, Kietpeerakool C. A Case Report of High-Grade Endometrial Stromal Sarcoma: A Rare Cause of Abnormal Uterine Bleeding in a Young Woman. Case Rep Obstet Gynecol 2018;2018:5906760. [PMID: 30622826 DOI: 10.1155/2018/5906760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2019. [DOI: 10.1007/978-3-319-96830-8_31] [Reference Citation Analysis]
36 Howitt BE, Nucci MR. Uterine Mesenchymal Lesions. Gynecologic and Obstetric Pathology, Volume 2 2019. [DOI: 10.1007/978-981-13-3019-3_1] [Reference Citation Analysis]
37 Fadare O, Roma AA. Mesenchymal and Miscellaneous Neoplasms of the Uterine Corpus. Atlas of Anatomic Pathology 2019. [DOI: 10.1007/978-3-030-17931-1_5] [Reference Citation Analysis]
38 Murdock TA, Veras EFT, Kurman RJ, Mazur MT. Mesenchymal Tumors and Other Rare Neoplasms. Diagnosis of Endometrial Biopsies and Curettings 2019. [DOI: 10.1007/978-3-319-98608-1_11] [Reference Citation Analysis]
39 Rekhtman N, Baine MK, Bishop JA. Immunostains: Solid Tumors. Quick Reference Handbook for Surgical Pathologists 2019. [DOI: 10.1007/978-3-319-97508-5_2] [Reference Citation Analysis]
40 Kyriazoglou A, Liontos M, Ziogas DC, Zagouri F, Koutsoukos K, Tsironis G, Tsiara A, Kaparelou M, Zakopoulou R, Thomakos N, Haidopoulos D, Papaspyrou I, Rodolakis A, Bamias A, Dimopoulos MA. Management of uterine sarcomas and prognostic indicators: real world data from a single-institution. BMC Cancer 2018;18:1247. [PMID: 30541504 DOI: 10.1186/s12885-018-5156-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
41 Tsuyoshi H, Yoshida Y. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma. Cancer Sci 2018;109:1743-52. [PMID: 29660202 DOI: 10.1111/cas.13613] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
42 Köhler G, Zygmunt MT. Uterine Sarcomas and Atypical Smooth-Muscle Tumors: Clinic, Diagnostics and Appropriate Surgical Therapy. Hysterectomy 2018. [DOI: 10.1007/978-3-319-22497-8_14] [Reference Citation Analysis]
43 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_10-2] [Reference Citation Analysis]
44 Lewis N, Soslow RA, Delair DF, Park KJ, Murali R, Hollmann TJ, Davidson B, Micci F, Panagopoulos I, Hoang LN, Arias-Stella JA 3rd, Oliva E, Young RH, Hensley ML, Leitao MM Jr, Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth AA, Antonescu CR, Chiang S. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. Mod Pathol 2018;31:674-84. [PMID: 29192652 DOI: 10.1038/modpathol.2017.162] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 19.4] [Reference Citation Analysis]
45 Lax SF. [New features in the 2014 WHO classification of uterine neoplasms]. Pathologe 2016;37:500-11. [PMID: 27738815 DOI: 10.1007/s00292-016-0230-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
46 Hoang LN, Aneja A, Conlon N, Delair DF, Middha S, Benayed R, Hensley ML, Park KJ, Hollmann TJ, Hameed MR, Antonescu CR, Soslow RA, Chiang S. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma. Am J Surg Pathol 2017;41:12-24. [PMID: 27631520 DOI: 10.1097/PAS.0000000000000721] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 16.8] [Reference Citation Analysis]
47 Vroobel KM, Karawita TS, Wilkinson N. New developments in endometrial stromal sarcoma. Diagnostic Histopathology 2017;23:311-22. [DOI: 10.1016/j.mpdhp.2017.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
48 Xie W, Bi X, Cao D, Yang J, Shen K, You Y. Primary endometrioid stromal sarcomas of the ovary: a clinicopathological study of 14 cases with a review of the literature. Oncotarget 2017;8:63345-52. [PMID: 28968994 DOI: 10.18632/oncotarget.18805] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
49 Chiang S, Lee CH, Stewart CJR, Oliva E, Hoang LN, Ali RH, Hensley ML, Arias-Stella JA 3rd, Frosina D, Jungbluth AA, Benayed R, Ladanyi M, Hameed M, Wang L, Kao YC, Antonescu CR, Soslow RA. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Mod Pathol 2017;30:1251-61. [PMID: 28621321 DOI: 10.1038/modpathol.2017.42] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 17.6] [Reference Citation Analysis]
50 Hemming ML, Wagner AJ, Nucci MR, Chiang S, Wang L, Hensley ML, George S. YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy. Gynecol Oncol 2017;145:531-5. [PMID: 28390819 DOI: 10.1016/j.ygyno.2017.03.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
51 Kubo T, Sugita S, Wada R, Kikuchi N, Iwasaki M, Ito Y, Sugawara T, Fujita H, Emori M, Tanaka R, Hirano H, Saito T, Hasegawa T. Uterine epithelioid leiomyosarcoma with c-kit expression and YWHAE gene rearrangement: a case report of a diagnostic pitfall of uterine sarcoma. Diagn Pathol 2017;12:26. [PMID: 28288693 DOI: 10.1186/s13000-017-0615-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
52 Howitt BE, Nucci MR. Molecular Pathology of Uterine Mesenchymal Tumors. Molecular Pathology Library 2017. [DOI: 10.1007/978-3-319-57985-6_11] [Reference Citation Analysis]
53 Hrzenjak A. JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas. Orphanet J Rare Dis 2016;11:15. [PMID: 26879382 DOI: 10.1186/s13023-016-0400-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
54 Endometrial Stromal Sarcoma. Diagnostic Pathology: Soft Tissue Tumors 2016. [DOI: 10.1016/b978-0-323-37675-4.50211-8] [Reference Citation Analysis]
55 Uterine Sarcomas. Diagnostic Pathology: Molecular Oncology 2016. [DOI: 10.1016/b978-0-323-37678-5.50175-4] [Reference Citation Analysis]
56 Boyd LR. Management of Uterine Sarcomas. Current Clinical Oncology 2016. [DOI: 10.1007/7631_2016_13] [Reference Citation Analysis]
57 Zhang Q, Wei J. Putative Precursors of Uterine Sarcomas. Precancerous Lesions of the Gynecologic Tract 2016. [DOI: 10.1007/978-3-319-22509-8_6] [Reference Citation Analysis]
58 Cuppens T, Tuyaerts S, Amant F. Potential Therapeutic Targets in Uterine Sarcomas. Sarcoma 2015;2015:243298. [PMID: 26576131 DOI: 10.1155/2015/243298] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
59 Guo X, Forgó E, van de Rijn M. Molecular subtyping of leiomyosarcoma with 3' end RNA sequencing. Genom Data 2015;5:366-7. [PMID: 26240788 DOI: 10.1016/j.gdata.2015.06.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
60 Guo X, Jo VY, Mills AM, Zhu SX, Lee CH, Espinosa I, Nucci MR, Varma S, Forgó E, Hastie T, Anderson S, Ganjoo K, Beck AH, West RB, Fletcher CD, van de Rijn M. Clinically Relevant Molecular Subtypes in Leiomyosarcoma. Clin Cancer Res 2015;21:3501-11. [PMID: 25896974 DOI: 10.1158/1078-0432.CCR-14-3141] [Cited by in Crossref: 100] [Cited by in F6Publishing: 103] [Article Influence: 14.3] [Reference Citation Analysis]
61 Hagemann IS, Pfeifer JD, Huettner PC. The uterine corpus. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2015. [DOI: 10.1017/9781139137201.039] [Reference Citation Analysis]
62 Baker PM, Oliva E. Prognostic Factors in Uterine Cancer. Current Clinical Oncology 2015. [DOI: 10.1007/7631_2015_4] [Reference Citation Analysis]
63 Kaspar HG, Crum CP. Uterus. Handbook of Practical Immunohistochemistry 2015. [DOI: 10.1007/978-1-4939-1578-1_19] [Reference Citation Analysis]
64 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2015. [DOI: 10.1007/978-1-4939-0727-4_27] [Reference Citation Analysis]
65 Desouki MM, Fadare O. Gynecologic Tumors. Molecular Oncology Testing for Solid Tumors 2015. [DOI: 10.1007/978-3-319-16304-8_15] [Reference Citation Analysis]
66 Conklin CM, Longacre TA. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol 2014;21:383-93. [PMID: 25299308 DOI: 10.1097/PAP.0000000000000046] [Cited by in Crossref: 117] [Cited by in F6Publishing: 126] [Article Influence: 14.6] [Reference Citation Analysis]
67 Spindle-cell and myxoid lesions. Diagnosis of Neoplasia in Endometrial Biopsies 2014. [DOI: 10.1017/cbo9781139628976.006] [Reference Citation Analysis]
68 Round-cell lesions. Diagnosis of Neoplasia in Endometrial Biopsies 2014. [DOI: 10.1017/cbo9781139628976.007] [Reference Citation Analysis]
69 Epithelioid-cell lesions. Diagnosis of Neoplasia in Endometrial Biopsies 2014. [DOI: 10.1017/cbo9781139628976.008] [Reference Citation Analysis]
70 Guo X, Zhu SX, Brunner AL, van de Rijn M, West RB. Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer. Breast Cancer Res 2013;15:R117. [PMID: 24342436 DOI: 10.1186/bcr3586] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
71 van de Rijn M, Guo X, Sweeney RT, Beck AH, West RB. Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities. Histopathology 2014;64:163-70. [PMID: 24107169 DOI: 10.1111/his.12290] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
72 Feng W, Malpica A, Skaland I, Gudlaugsson E, Robboy SJ, Dalen I, Hua K, Zhou X, Baak JP. Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade? PLoS One 2013;8:e75899. [PMID: 24146786 DOI: 10.1371/journal.pone.0075899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
73 Binesh F, Zahir ST, Akhavan A, Bovanlu TR. Endometrial stromal sarcoma of the uterus presenting as pulmonary metastasis. BMJ Case Rep 2013;2013:bcr2013008565. [PMID: 23907964 DOI: 10.1136/bcr-2013-008565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
74 Sardinha R, Hernández T, Fraile S, Tresserra F, Vidal A, Gómez MC, Astudillo A, Hernández N, Saenz de Santamaría J, Ordi J, Gonçalves L, Ramos R, Balañá C, de Álava E. Endometrial stromal tumors: immunohistochemical and molecular analysis of potential targets of tyrosine kinase inhibitors. Clin Sarcoma Res 2013;3:3. [PMID: 23497641 DOI: 10.1186/2045-3329-3-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
75 Maki RG, Iqbal A. Uterine Sarcomas in the Elderly. Management of Gynecological Cancers in Older Women 2013. [DOI: 10.1007/978-1-4471-4605-6_20] [Reference Citation Analysis]
76 Tumors of the breast and female genital organs. Modern Immunohistochemistry 2000. [DOI: 10.1017/cbo9781316167366.008] [Reference Citation Analysis]